Description
This presentation features Dr. Joshua Jones, a Clinical Phage Specialist and Director of UK Phage Therapy, who discusses the emerging field of phage therapy as a potential alternative to antibiotics, particularly for antibiotic-resistant infections. Joshua explains that phages are naturally occurring viruses that specifically infect and kill bacteria, which are found in vast quantities globally. He presents an insightful overview of the history and current status of phage therapy, detailing its advantages, such as minimal side effects and efficacy against multi-drug resistant bacteria, as well as the challenges, including the current lack of standardized protocols and the necessity for personalized treatment plans. Throughout the session, he encourages ongoing discussion and collaboration among clinicians interested in phage therapy, providing practical insights into patient selection, timelines for therapy implementation, and the importance of addressing the evidence paradox in clinical trials. He concludes by inviting queries from participants, reflecting the growing interest and potential of phage therapy as a viable treatment option.